Ebola Drugmaker Shares Surge After CDC Confirms First US Case

Advertisement

ebola

Flickr/NIAID

Colorized scanning electron micrograph of filamentous Ebola virus particles (green) attached and budding from a chronically infected VERO E6 cell (orange) (25,000x magnification).

Shares of Tekmira Pharmaceuticals, which is working on a treatment for Ebola, are surging in after hours trade after the Centers for Disease Control confirmed the first case of Ebola in the US.

Advertisement

Shares of Tekmira were up as much 11% on Tuesday evening.

The CDC is set to hold a press conference at 5:30 pm ET on Tuesday.

More to come ...